Patent · US Expired

Oxopyridinyl pharmaceutical compositions and methods for use

US6455554B1 · kind B1 · utility

62Cited by

44References

15Claims

0Family size

Assignee

Targacept, Inc. · US

Inventors

Gary Maurice Dull · Lewisville, US
Craig Harrison Miller · Winston-Salem, US
William Scott Caldwell · Winston-Salem, US
Dwo Lynm · Winston-Salem, US
Balwinder Singh Bhatti · Winston-Salem, US
Jeffrey Daniel Schmitt · Winston-Salem, US
Gary Dwight Byrd · Winston-Salem, US

Key dates

Filing date	May 12, 2000
Grant date	Sep 24, 2002
Priority date	—
Expiry date	May 12, 2020

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D239/42
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Pharmaceutical compositions incorporate aryl substituted olefinic amine compounds. Representative compounds are (2S)-(4E)-N-methyl-5-[3-(5-isopropoxy-1-oxopyridin)yl)]-4-penten-2-amine, (4E)-N-methyl-5-(3-(1-oxopyridin)yl)-4-penten-2-amine, (4E)-N-methyl-5-(3-(5-((carboxymethyl)oxy)pyridin)yl)-4-penten-2-amine and (4E)-N-methyl-5-(3-(1-oxopyridin)yl)-4-penten-2-amine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.